EGCG


Also found in: Medical.
AcronymDefinition
EGCGEpigallocatechin Gallate (antioxidant in green tea)
EGCGExternal Gender Consultative Group (est. 1996; World Bank)
EGCGEpithelioid-Giant Cell Granuloma (pediatric gastroenterology)
References in periodicals archive ?
In terms of chemical strength, servings yielded from 25 mg to 86 mg of EGCG, one of the key "catechin" compounds in green tea and a natural phenol in the flavanol family.
The EGCG had no significant effect on blood sugar spikes in mice that were fed glucose or maltose, according to the researchers who released their findings in the online version of Molecular Nutrition and Food Research.
However, the solutions of GTE and EGCG were neutral pH values, thus they did not lower the pH in the intestinal lumen, suggesting the ionized amount of nadolol was not changed by the administrations of green tea catechin solution.
The results of the current study with significant weight reduction and decreased ghrelin levels after EGCG treatment imply that a high dose of EGCG might increase energy metabolism and interrupt lipid accumulation and directly inhibit ghrelin secretion.
The aim of this study was to determine the potential of the prepared porous materials to adsorb, separate, and purify EGCG.
The study compared the effects of EGCG in human oral squamous carcinoma cells, pre-malignant cells, and normal human gingival fibroblasts.
The study, titled "Beneficial Effects of Dietary EGCG and Voluntary Exercise on Behavior in an Alzheimer's Disease Mouse Model," and which was published in the Journal of Alzheimer's Disease in March 2015, found that information retention and mental acuity were significantly improved after the dosing of green tea extract and exercises, and A-beta levels dropped.
The Moffitt researchers observed a significant increase in the levels of EGCG in the blood plasma of men on Polyphenon E, and the capsules at this dose were tolerated in this group of men.
EGCG appears to affect the relationship between endothelial dysfunction and diseases involving insulin resistance, including diabetes and metabolic syndrome, and in turn their vascular complications (Wolfram et al.
Group 1 served as control and groups 2, 3, and 4 were treated with TQ (16 [micro]M), EGCG (3 pg/ml), and TQ + EGCG, respectively.
Teavigo brand EGCG had previously been distributed under license by Pharmachem Laboratories, Inc.
Using sophisticated metabolic profiling methods, the researchers found EGCG disrupted the balance of "flux" throughout the cellular metabolic network.